SCHEMBL26036096

CSc1nnc(-c2ccc(OCCNC(=O)C(CNC(=O)CC(C)(C)COCC(C)(C)CNC(=O)CC(C)(C)OCC(C)(C)CNC(=O)C(C)C)CNC(=O)CC(C)(C)COCC(C)(C)CNC(=O)CC(C)(C)OCC(C)(C)CNC(=O)C(C)(C)CC(C)(C)C)cc2)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL26036084	0.94	—	—
SCHEMBL26036103	0.81	CXCR4 (0.33)	—
SCHEMBL25840443	0.77	—	—
SCHEMBL26036113	0.75	TSHR (0.30)	—
SCHEMBL26037563	0.74	—	—
SCHEMBL25851802	0.74	ALDH1A1 (0.46)	—
SCHEMBL26036141	0.72	TP53 (0.31)	—
SCHEMBL25840454	0.70	NPC1 (0.32)	—
SCHEMBL26047845	0.69	—	—
SCHEMBL25851756	0.68	TP53 (0.50)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230265429-A1	SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE THEREOF	Arrowhead Pharmaceuticals, Inc.	2023-08-24	—	—	US	disclosed